Rapid Antigen & Lateral-Flow Tests

A rapid antigen test (RAT) is the paper strip that made at-home testing a household routine. It detects a pathogen protein (antigen) directly from a swab or saliva, with no instrument, no power, and a result in about fifteen minutes. The underlying format — the lateral-flow immunoassay — is the same one used by pregnancy tests, and its speed and simplicity come with a defining limitation: it is far less sensitive than a molecular test.

How the strip works

The specimen is mixed with a buffer and dripped onto a pad, and capillary action wicks it along a nitrocellulose strip past three zones.

1. A conjugate pad holds antibodies against the target antigen, tagged with colored gold nanoparticles or latex. If the antigen is present, it binds these labeled antibodies and is carried along.
2. The test line is coated with a second, immobilized antibody against the antigen. Antigen sandwiched between the mobile and fixed antibodies concentrates the colored label into a visible line.
3. The control line captures excess labeled antibody regardless of antigen, confirming the test ran correctly.

Two lines means positive; one line (control only) means negative; no control line means the test is invalid.

Sensitivity tracks pathogen load

The single most important fact about rapid antigen tests is that their sensitivity depends on how much antigen is present, which depends on when in the infection you test. A RAT needs a relatively high antigen concentration to cross its detection threshold, so it is most likely to be positive during the days of peak load — often around symptom onset — and misses early and late infection where a PCR would still detect nucleic acid.

The practical response is serial testing: repeating a rapid test every day or two dramatically raises the chance of catching the infection during its detectable window, partly compensating for the lower single-test sensitivity.

Positive predictive value and prevalence

Rapid tests are usually built for high specificity, so a positive is generally trustworthy. But the value of a positive still depends on how common the disease is. The positive predictive value,

$$\text{PPV} = \frac{\text{sens}\cdot p}{\text{sens}\cdot p + (1-\text{spec})(1-p)},$$

collapses when prevalence $p$ is very low — even a 99%-specific test throws mostly false positives when almost no one is infected — which is the core argument for confirming unexpected positives and for interpreting screening results in light of the tested population.

Trade-offs & resource considerations

• Sensitivity & specificity. Low-to-moderate sensitivity (worst near the edges of the diagnostic window), but high specificity. Sensitivity is best expressed conditional on viral load, not as a single headline number.
• Cost. Very low per test, no instrument — the least resource-intensive option available.
• Training & infrastructure. Essentially none; designed for lay users and the bedside, with no cold chain for many formats.
• Turnaround. ~15 minutes, at the point of care — its entire reason for existing.
• Where it fits. Rapid tests trade analytical sensitivity for access and speed. For controlling transmission, a same-minute answer that someone acts on can outperform a more sensitive result that arrives after they have already spread the pathogen.

Why it matters

Rapid antigen tests reframed testing from a laboratory service into a personal, repeatable behavior. Understanding why they miss early infection, why serial testing rescues much of that sensitivity, and why a positive’s meaning depends on prevalence is essential to using them well — and to reading the surveillance signals they generate.

Related

• qPCR and RT-qPCR
• ELISA
• Diagnostic Testing and Screening — sensitivity, specificity, PPV
• Diagnostics & Surveillance